Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Metabotropic glutamate receptor 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Onchocerca volvulus | Cell death abnormality protein 8 homolog | Metabotropic glutamate receptor 2 | 872 aa | 883 aa | 43.3 % |
Onchocerca volvulus | Golgi-associated plant pathogenesis-related protein 1 homolog | Metabotropic glutamate receptor 2 | 872 aa | 884 aa | 35.3 % |
Schistosoma mansoni | metabotropic glutamate receptor | Metabotropic glutamate receptor 2 | 872 aa | 892 aa | 26.9 % |
Onchocerca volvulus | Metabotropic glutamate receptor 2 | 872 aa | 774 aa | 20.4 % | |
Loa Loa (eye worm) | hypothetical protein | Metabotropic glutamate receptor 2 | 872 aa | 822 aa | 21.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.047 | 0.047 |
Brugia malayi | Trypsin family protein | 0.0172 | 0.047 | 0.047 |
Schistosoma mansoni | hypothetical protein | 0.0523 | 0.8441 | 0.908 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0559 | 0.9248 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0592 | 1 | 1 |
Toxoplasma gondii | kringle domain-containing protein | 0.0559 | 0.9248 | 1 |
Onchocerca volvulus | 0.0523 | 0.8441 | 0.8364 | |
Echinococcus granulosus | laminin | 0.018 | 0.0641 | 0.0195 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0559 | 0.9248 | 0.9248 |
Brugia malayi | Chymotrypsin-like protease CTRL-1 precursor | 0.0172 | 0.047 | 0.047 |
Onchocerca volvulus | 0.0592 | 1 | 1 | |
Echinococcus multilocularis | Tolloid protein 1 | 0.0236 | 0.1923 | 0.1655 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0229 | 0.1752 | 0.146 |
Leishmania major | hypothetical protein, conserved | 0.0559 | 0.9248 | 0.5 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0559 | 0.9248 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0172 | 0.047 | 0.5 |
Brugia malayi | Trypsin family protein | 0.0172 | 0.047 | 0.047 |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.047 | 0.047 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0559 | 0.9248 | 0.5 |
Onchocerca volvulus | 0.0559 | 0.9248 | 0.9211 | |
Loa Loa (eye worm) | hypothetical protein | 0.0523 | 0.8441 | 0.8441 |
Schistosoma mansoni | hypothetical protein | 0.0559 | 0.9248 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.047 | 0.047 |
Schistosoma mansoni | subfamily M12A unassigned peptidase (M12 family) | 0.0236 | 0.1923 | 0.1655 |
Echinococcus granulosus | Tolloid protein 1 | 0.0236 | 0.1923 | 0.1655 |
Brugia malayi | Low-density lipoprotein receptor repeat class B containing protein | 0.0275 | 0.2806 | 0.2806 |
Schistosoma mansoni | egf-like domain protein | 0.018 | 0.0641 | 0.0195 |
Loa Loa (eye worm) | multiple epidermal growth factor-like domains 6 | 0.018 | 0.0641 | 0.0641 |
Loa Loa (eye worm) | hypothetical protein | 0.0275 | 0.2806 | 0.2806 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0559 | 0.9248 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0331 | 0.4087 | 0.4087 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.0641 | 0.0641 |
Brugia malayi | Trypsin family protein | 0.0172 | 0.047 | 0.047 |
Brugia malayi | Kringle domain containing protein | 0.0559 | 0.9248 | 0.9248 |
Loa Loa (eye worm) | bone morphogenetic protein 1b | 0.0236 | 0.1923 | 0.1923 |
Brugia malayi | Trypsin family protein | 0.0172 | 0.047 | 0.047 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.0641 | 0.0641 |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.047 | 0.047 |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.0523 | 0.8441 | 0.8441 |
Brugia malayi | Protein kinase domain containing protein | 0.0559 | 0.9248 | 0.9248 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0324 | 0.3916 | 0.3926 |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.047 | 0.047 |
Loa Loa (eye worm) | trypsin family protein | 0.0172 | 0.047 | 0.047 |
Loa Loa (eye worm) | hypothetical protein | 0.0236 | 0.1923 | 0.1923 |
Brugia malayi | hypothetical protein | 0.0172 | 0.047 | 0.047 |
Brugia malayi | Trypsin-like protease protein 5 | 0.0172 | 0.047 | 0.047 |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.047 | 0.047 |
Onchocerca volvulus | 0.0523 | 0.8441 | 0.8364 | |
Onchocerca volvulus | 0.0523 | 0.8441 | 0.8364 | |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.047 | 0.047 |
Brugia malayi | SEA domain containing protein | 0.0523 | 0.8441 | 0.8441 |
Loa Loa (eye worm) | hypothetical protein | 0.0559 | 0.9248 | 0.9248 |
Brugia malayi | Calcium binding EGF domain containing protein | 0.018 | 0.0641 | 0.0641 |
Loa Loa (eye worm) | low-density lipoprotein receptor repeat class B containing protein | 0.0275 | 0.2806 | 0.2806 |
Echinococcus multilocularis | laminin | 0.018 | 0.0641 | 0.0195 |
Onchocerca volvulus | 0.0523 | 0.8441 | 0.8364 | |
Onchocerca volvulus | Arrow homolog | 0.0275 | 0.2806 | 0.2451 |
Brugia malayi | Fibulin-1 precursor | 0.018 | 0.0641 | 0.0641 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0559 | 0.9248 | 1 |
Echinococcus multilocularis | fibrillin 1 | 0.018 | 0.0641 | 0.0195 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (binding) | = 1620 nM | Positive allosteric modulation of rat mGluR2 expressed in HEK293 cells co-expressing Galpha15 G protein assessed as increase in glutamate-induced intracellular calcium release by FLIPR assay | ChEMBL. | 21366332 |
Ki (binding) | Displacement of [3H]spiperone from dopamine D2 receptor in rat corpus striatum by beta plate scintillation counting | ChEMBL. | 21366332 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.